Komori
Pharma Foods International (2929) · TargetReframed

Medium-Term Management Plan Theme: “Creating New Value”

First written in FY2022-Q1. 10 of 17 entries say "Restated". Latest entry: FY2026.

17entries
6years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023-Q1 – FY2023-Q2RestatedFY2024-Q1 – 2026-06-102021: 12022: 420222023: 320232024: 220242025: 020252026: 72026
Same theme, other companies
Originality as the Source of New Value and Market CreationA theme 8 companies write about · 0 as a headwind · 8 as a tailwind

0 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「Going forward, under a new medium-term management plan and building on the R&D capabilities and business platform developed to date, we will enhance the growth potential of each business and accelerate initiatives aimed at creating new value.」

    While continuing the New Value Creation 1K Project under Medium-Term Management Plan 2026, the description has shifted to a stage of accelerating growth in each business and value creation toward the next medium-term management plan.
  2. FY2024RestatedAnnual report

    「In the medium-term management plan formulated in July 2021, the group's core theme is the creation of "new value (new products, new markets and a new organization)."」

    The company continues the core theme of its medium-term management plan, "New Value Creation," comprising 3 pillars: new products, new markets and a new organization.
  3. FY2024-Q2RestatedAnnual report

    「To become a leading company capable of meeting these healthcare needs, we have established the "New Value Creation 1K Project" as the theme of the Medium-Term Management Plan 2026. To achieve this, we focused on R&D investment, development of new products and sales channels, and strengthening the organizational structure.」

    The company continues the "New Value Creation 1K Project," the theme of the Medium-Term Management Plan 2026, together with initiatives in R&D, new products, sales channels and the organizational structure as means of achieving it.
  4. FY2024-Q1RestatedAnnual report

    「To meet these needs, we established the theme of the Medium-Term Management Plan 2026, the "New Value Creation 1K Project," and focused on R&D investment, development of new products and development of sales channels, and strengthening the organizational structure to achieve it.」

    The company continues the "New Value Creation 1K Project" under the Medium-Term Management Plan 2026, together with initiatives in R&D, new products, sales channels and the organizational structure as means of achieving it.
  5. FY2023ReframedAnnual report

    「In the medium-term management plan formulated in July 2021, the group's core theme is the creation of "new value (new products, new markets and a new organization)."」

    The recent expression "New Value Creation 1K Project" has been organized as a core theme comprising 3 pillars: new products, new markets and a new organization.
  6. FY2023-Q2RestatedAnnual report

    「To meet these needs and achieve the "New Value Creation 1K Project," the theme of the Medium-Term Management Plan 2026, we focused on R&D investment, including active development of new materials and stronger recruitment of researchers, and advertising investment in new and core products.」

    The company continues the "New Value Creation 1K Project" under the Medium-Term Management Plan 2026, using R&D, recruitment and advertising investment as means of achieving it.
  7. FY2023-Q1RestatedAnnual report

    「To meet these needs and achieve the "New Value Creation 1K Project," the theme of the Medium-Term Management Plan 2026, we focused on R&D investment, including active development of new materials and stronger recruitment of researchers, and advertising investment in new and core products.」

    The company continues the "New Value Creation 1K Project" under the Medium-Term Management Plan 2026, using R&D, recruitment and advertising investment as means of achieving it.
  8. FY2022ReframedAnnual report

    「In the medium-term management plan formulated in July 2021, the group's core theme is the creation of "new value (new products, new markets and a new organization)."」

    The former expression "New Value Creation 1K Project" has been organized around 3 pillars: new products, new markets and a new organization, with initiatives specified for each pillar.
  9. FY2022-Q3RestatedAnnual report

    「To meet these needs and achieve the "New Value Creation 1K Project," the theme of the Medium-Term Management Plan 2026, we focused on R&D investment, including development of new materials and stronger recruitment of researchers, advertising investment in new and core products, promotion of M&A and the establishment of alliances.」

    The company continues the "New Value Creation 1K Project" as a theme of its medium-term management plan, using R&D, advertising, M&A and alliances as means of achieving it.
  10. FY2022-Q2ReframedAnnual report

    「To meet these needs and achieve the "New Value Creation 1K Project," the theme of the Medium-Term Management Plan 2026, we focused on R&D investment, including development of new materials and stronger recruitment of researchers, advertising investment in new and core products, promotion of M&A and the establishment of alliances.」

    The former medium-term management plan theme, "New Value Creation," has been reorganized under the Medium-Term Management Plan 2026 as the specific plan name and set of initiatives called the "New Value Creation 1K Project."
  11. FY2022-Q1First statedAnnual report

    「To meet these needs and achieve the medium-term management plan theme of "New Value Creation," the group actively invested in R&D for its functional materials and biomedical businesses, with particular emphasis on strengthening recruitment of R&D personnel. In the mail-order business, it continued to make high-level investments in existing products while maintaining efficiency, and actively invested in expanding sales of new products.」

    The company identified "New Value Creation" for the first time as a theme of its medium-term management plan, citing stronger recruitment of R&D personnel, R&D investment and investment in existing and new products as means of achieving it.
Moved together

"Higher revenue and narrower loss in the biomedical business" moved the same way as this thread, in the same document, in 4 of its 17 moves.

432222★123456
  1. ★This thread
  2. 1Higher revenue and narrower loss in the biomedical business4×
  3. 2Decrease in Cash and Cash Equivalents3×
  4. 3Guarantee Obligations to Affiliates and Business Partners2×
  5. 4Meiji Pharmaceutical's Negative Net Worth and Losses2×
  6. 5Functional Materials business: lower revenue and profit2×
  7. 6Rapid Growth of the Mail-Order Business and the Burden of Upfront Investment2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Pharma Foods International yet. It last moved in the Business Plan of 2026-10-16: "Reframed".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Medium-Term Management Plan Theme: “Creating New Value” | Pharma Foods International Co.,Ltd. (2929) | Komori